AU2158799A - Polyrotaxanes - Google Patents

Polyrotaxanes

Info

Publication number
AU2158799A
AU2158799A AU21587/99A AU2158799A AU2158799A AU 2158799 A AU2158799 A AU 2158799A AU 21587/99 A AU21587/99 A AU 21587/99A AU 2158799 A AU2158799 A AU 2158799A AU 2158799 A AU2158799 A AU 2158799A
Authority
AU
Australia
Prior art keywords
polyrotaxanes
mrt
iodine
relates
metal complexes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21587/99A
Inventor
Johannes Dr. Platzek
Heribert Schmitt-Willich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU2158799A publication Critical patent/AU2158799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/007—Polyrotaxanes; Polycatenanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Polyethers (AREA)

Abstract

The invention relates to polyrotaxanes containing metal complexes or iodine benzol derivatives for MRT and X-ray diagnosis.
AU21587/99A 1997-12-17 1998-12-09 Polyrotaxanes Abandoned AU2158799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19758118A DE19758118A1 (en) 1997-12-17 1997-12-17 Polyrotaxanes
DE19758118 1997-12-17
PCT/EP1998/007924 WO1999030744A1 (en) 1997-12-17 1998-12-09 Polyrotaxanes

Publications (1)

Publication Number Publication Date
AU2158799A true AU2158799A (en) 1999-07-05

Family

ID=7853528

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21587/99A Abandoned AU2158799A (en) 1997-12-17 1998-12-09 Polyrotaxanes

Country Status (5)

Country Link
EP (1) EP1037671B1 (en)
AT (1) ATE232111T1 (en)
AU (1) AU2158799A (en)
DE (2) DE19758118A1 (en)
WO (1) WO1999030744A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6013190B2 (en) 2010-12-16 2016-10-25 住友精化株式会社 Method for producing pseudopolyrotaxane
CA2821905C (en) 2010-12-16 2018-07-10 Sumitomo Seika Chemicals Co., Ltd. Method for producing pseudopolyrotaxane aqueous dispersion
WO2012081429A1 (en) * 2010-12-16 2012-06-21 住友精化株式会社 Method for producing pseudopolyrotaxane
KR101817381B1 (en) 2011-03-14 2018-01-11 스미또모 세이까 가부시키가이샤 Production method for hydrophilic modified polyrotaxane
CA2829862C (en) 2011-03-14 2017-10-24 Advanced Softmaterials Inc Production method for powdered hydrophilic modified polyrotaxane

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8522535D0 (en) * 1985-09-11 1985-10-16 Amersham Int Plc Contrast agent
WO1987002893A1 (en) * 1985-11-18 1987-05-21 Board Of Regents, The University Of Texas System Polychelating agents for image and spectral enhancement (and spectral shift)
GB8923843D0 (en) * 1989-10-23 1989-12-13 Salutar Inc Compounds
DE3938992A1 (en) * 1989-11-21 1991-05-23 Schering Ag Cascade polymer-bound complex formers, their complexes and conjugates, process for their preparation and pharmaceutical compositions containing them
EP0766968B1 (en) * 1995-10-06 2001-01-17 Nihon Medi-Physics Co., Ltd. Diagnostic imaging agent
DE19629494A1 (en) * 1996-07-09 1998-01-15 Schering Ag Pseudopolyrotaxanes

Also Published As

Publication number Publication date
ATE232111T1 (en) 2003-02-15
WO1999030744A1 (en) 1999-06-24
EP1037671B1 (en) 2003-02-05
EP1037671A1 (en) 2000-09-27
DE59807141D1 (en) 2003-03-13
DE19758118A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
AU6645196A (en) Metal complexes for use as gas generants
EP0609937A3 (en) Monetary instruments.
HK1026632A1 (en) Stable complexes of poorly soluble compounds.
EP0600413A3 (en) Neuro endoscope for shunt.
AU3451695A (en) X-ray visible stent
AU2054097A (en) Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
EP0647826A3 (en) Generative measuring system.
EP0645276A3 (en) Combination instrument.
AU676400B2 (en) Flush-interval indicator for soluble pouches
IL114294A0 (en) Sterol derivatives
AU3553793A (en) Austenitic molybdenum alloy
AU9342898A (en) Contrasting agent for infarct and necrosis imaging
WO1994026263A3 (en) Use of a transition metal complex for the treatment of septic shock
AU3632400A (en) Metal complexes containing bridging heteroatom for olefin-polymerization-process
AU2158799A (en) Polyrotaxanes
AU648315B2 (en) The use of macrocyclic aminophosphonic acid complexes as imaging agents
AU4932899A (en) Processes for the preparation of metallocene complexes
AU3410099A (en) Pharmaceutical compositions containing melatonin inclusion complexes
PH31305A (en) Phase shift colloids as ultrasound contrast agents.
AU3290197A (en) Halopropargyl inclusion complexes
AU1816395A (en) X-ray contrast compositions containing cellulose derivatives
IL111817A0 (en) Halogen-containing metal complexes, diagnostic agents containing the same and processes for the preparation thereof
AU4222599A (en) Poly-oxyanions as anchoring agents for metal complexes
AU675568B2 (en) Antitumor agent
AU4922399A (en) Bicyclohexane derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase